✦ LIBER ✦

Drug-related adverse events may predict efficacy in sorafenib therapy for hepatocellular carcinoma

✍ Scribed by Yan Zhao; Man Yang; Xingshun Qi; Guohong Han; Daiming Fan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mo1039 Safety Profile of Sorafenib in He

✍ Abbas, Ali; Khullar, Vikas; Horne, Patrick; Mills, Rennie; Cabrera, Roniel 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Sorafenib in hepatocellular carcinoma: p

✍ Paola Rita Brunocilla, Franco Brunello, Patrizia Carucci, Silvia Gaia, Emanuela 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 281 KB

Strategies for assessing and managing th

✍ Kim Edmonds; Diana Hull; Andrea Spencer-Shaw; José Koldenhof; Maria Chrysou; Chr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 520 KB

226 EFFICACY AND SAFETY OF SORAFENIB AT

✍ M. Reig; A. Forner; C. Rodriguez de Lope; J. Rimola; S. Tremosini; C. Mestres; C 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB

The efficacy of acupoint stimulation for

✍ Li-Fen Chao; Anthony Lin Zhang; Hsueh-Erh Liu; Ming-Huei Cheng; Hung-Bun Lam; Si 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 280 KB

PP67 Early alpha-fetoprotein response pr

✍ Y.-Y. Shao; Z.-Z. Lin; C. Hsu; Y.-C. Shen; C.-H. Hsu; A.-L. Cheng 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 64 KB